| Entry |
|
|---|
| Name |
SARS-CoV-2 S/N to lectin pathway of coagulation cascade
|
|---|
| Definition |
(S,N) -> (MBL2,COLEC10/11,FCN) |
|---|
| Expanded |
(K24152,K24106) -> (4153,(10584,78989),(2219,2220,8547)) |
|---|
| Class |
nt06171 SARS coronavirus 2 (SARS-CoV-2)
|
|---|
| Type |
Pathogen
|
|---|
| Pathway |
|
|---|
| Disease |
|
|---|
| Gene |
| 4153 | MBL2; mannose binding lectin 2 |
| 10584 | COLEC10; collectin subfamily member 10 |
| 78989 | COLEC11; collectin subfamily member 11 |
|
|---|
| Perturbant |
| K24152 (S) | S; SARS coronavirus spike glycoprotein |
| K24106 (N) | N; SARS coronavirus nucleocapsid protein |
|
|---|
| Reference |
|
|---|
| Authors |
Lo MW, Kemper C, Woodruff TM |
|---|
| Title |
COVID-19: Complement, Coagulation, and Collateral Damage. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Jodele S, Kohl J |
|---|
| Title |
Tackling COVID-19 infection through complement-targeted immunotherapy. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G, Wallis R, Klavinskis LS, Sacks S |
|---|
| Title |
Rationale for targeting complement in COVID-19. |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
